Chimeric antigen receptor (CAR) T-Cell therapy is a form of immunotherapy that involves genetically engineering a patient's own T cells to recognize and attack cancer cells. The T cells are modified to express a chimeric antigen receptor (CAR) that specifically targets cancer cells, allowing the immune system to better combat the disease.